209 related articles for article (PubMed ID: 15477715)
1. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
Plöckinger U; Wiedenmann B
Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
[TBL] [Abstract][Full Text] [Related]
2. [Neuroendocrine tumours of the gastrointestinal tract].
Plöckinger U; Wiedenmann B
Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448
[TBL] [Abstract][Full Text] [Related]
3. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
Schillaci O; Corleto VD; Annibale B; Scopinaro F; Delle Fave G
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for gastro-enteropancreatic endocrine tumours.
O'Toole D; Hentic O; Corcos O; Ruszniewski P
Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
[TBL] [Abstract][Full Text] [Related]
5. Imaging of neuroendocrine tumours (CT/MR/US).
Rockall AG; Reznek RH
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):43-68. PubMed ID: 17382265
[TBL] [Abstract][Full Text] [Related]
6. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
7. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
8. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours.
Zamora V; Cabanne A; Salanova R; Bestani C; Domenichini E; Marmissolle F; Giacomi N; O'Connor J; Méndez G; Roca E;
Dig Liver Dis; 2010 Mar; 42(3):220-5. PubMed ID: 19819769
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Corleto V; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
Int J Oncol; 2003 Dec; 23(6):1687-95. PubMed ID: 14612942
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin-receptor mediated diagnosis and treatment in gastrointestinal neuroendocrine tumours (GEP-NET's).
Oberg K
Rocz Akad Med Bialymst; 2005; 50():62-8. PubMed ID: 16358941
[No Abstract] [Full Text] [Related]
14. Duodeno-pancreatic neuroendocrine tumours.
Peros G; Sakorafas GH; Konstantoudakis G; Giannopoulos GA; Petropoulou K; Parasi A
Eur J Cancer Care (Engl); 2010 May; 19(3):393-402. PubMed ID: 19708940
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumours.
O'Grady HL; Conlon KC
Eur J Surg Oncol; 2008 Mar; 34(3):324-32. PubMed ID: 17967523
[TBL] [Abstract][Full Text] [Related]
16. [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].
Zimmer T; Faiss S; Buhr HJ; Hamm B; Wiedenmann B
Bildgebung; 1995 Mar; 62(1):5-13. PubMed ID: 7756824
[TBL] [Abstract][Full Text] [Related]
17. [Localization diagnostics of neuroendocrine gastrointestinal tumours].
Kjaer A; Knigge U; Mortensen J; Hansen CP; Fallentin E
Ugeskr Laeger; 2010 Oct; 172(43):2953-6. PubMed ID: 21040674
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumours.
Alexakis N; Neoptolemos JP
Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
[TBL] [Abstract][Full Text] [Related]
19. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
Metz DC
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
